Bong Y. Koh
Bong Y. Koh has made 2 open-market purchases worth $38.3M since Oct 27, 2026, in 1 company. The latest: $645k of LYCA, filed Oct 30, 2026, scored 19 out of 100.
10% owner, Lycia Therapeutics, Inc.
Follow Bong Y. Koh, freeOpen the live feed
A free account gets an alert the minute a new buy or sale is filed.
Purchases
| Filed | Stock | Stake | Score | Bought | 1 week | 1 month |
|---|---|---|---|---|---|---|
| Oct 30 Form 4 (opens sec.gov) |
LYCALycia Therapeutics, Inc. · 10% owner10% owner | +0% stake | 19 | $645k 25,004 at $25.78 |
waiting | waiting |
| Oct 27 Form 4 (opens sec.gov) |
LYCALycia Therapeutics, Inc. · 10% owner10% owner | +43% stake | 36 | $37.7M 2,045,440 at $18.41 |
waiting | waiting |
Questions
What stock has Bong Y. Koh bought?
LYCA (Lycia Therapeutics, Inc.), all on the open market and reported on SEC Form 4.
When did Bong Y. Koh last buy?
Oct 30, 2026: 25,004 shares of LYCA at $25.78, $645k in all (Form 4 (opens sec.gov)).
Has Bong Y. Koh filed a notice of a planned sale?
Not in the filings on record. A Form 144 is the notice an insider must file before selling restricted or control shares, and it lands on EDGAR before the sale is reported.
Is Bong Y. Koh a routine or an opportunistic buyer?
There isn't enough history to say yet.
Data as of Oct 30, 2026, from SEC EDGAR Form 4 filings: open-market purchases (code P) of $25,000 or more, and open-market sales. Every row links to its filing. Scores summarise what a filing says (how the score works); outcomes are hypothetical, from the first close after the filing, and past results don't predict future ones. Disclaimer